Pujing Zhao

Pujing Zhao's research spans two areas: earlier work evaluated diabetes and cardiovascular drug safety (such as heart failure risks linked to diabetes medications) and clinical decision support systems for medication management, while more recent work focuses on mental health and substance use disorders, including opioid use disorder, antipsychotic medication adherence, and global burden of psychiatric conditions among young people. Much of the work uses systematic reviews, meta-analyses, and large healthcare claims or registry data (e.g., Medicaid beneficiaries) to study treatment outcomes and healthcare utilization.

Publication output has been low and intermittent over the last decade, with gaps in several years followed by a modest uptick in 2024-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026